A detailed history of Walleye Capital LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Walleye Capital LLC holds 28,547 shares of NPCE stock, worth $303,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,547
Holding current value
$303,740
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$5.9 - $11.93 $168,427 - $340,565
28,547 New
28,547 $319,000
Q1 2024

May 15, 2024

BUY
$9.78 - $17.5 $52,596 - $94,115
5,378 Added 37.56%
19,698 $260,000
Q4 2023

Feb 14, 2024

BUY
$5.9 - $10.31 $84,488 - $147,639
14,320 New
14,320 $147,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $264M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.